Table 1 Sample overview.
Total | Non-responder | Responder | Remitter | pa | |
|---|---|---|---|---|---|
n | 65 | 21 | 44 | 25 | |
Sex = M (%) | 28 (43.1) | 7 (33.3) | 21 (47.7) | 10 (40.0) | 0.408 |
Age (mean (SD)) | 50 (16.8) | 42.81 (16.01) | 53.43 (16.20) | 52.56 (17.44) | 0.016 |
MADRS_before (mean (SD)) | 35.09 (6.7) | 33.95 (5.38) | 35.64 (7.25) | 34.76 (7.47) | 0.348 |
MADRS_after (mean (SD)) | 14.02 (8.6) | 24.19 (5.44) | 9.16 (4.69) | 5.92 (2.69) | <0.001 |
MADRS_percent (mean (SD)) | 59.33 (24.8) | 28.65 (12.58) | 73.98 (12.76) | 82.43 (8.54) | <0.001 |
MADRS_delta (mean (SD)) | 21.08 (10.2) | 9.76 (4.62) | 26.48 (7.31) | 28.84 (7.30) | <0.001 |
No of ECT treatments (mean (SD)) | 10.23 (3.7) | 11.43 (3.91) | 9.35 (2.88) | 8.15 (2.58) | 0.126 |
Anti-depressant n (%) | 50 (76.9) | 15 (71.4) | 35 (79.5) | 20 (80.0) | 0.681 |
Antipsychotic n (%) | 51 (78.5) | 17 (81.0) | 34 (77.3) | 19 (76.0) | 0.988 |
Anticonvulsant n (%) | 3 (4.6) | 0 (0.0) | 3 (6.8) | 1 (4.0) | 0.553 |
Lithium n (%) | 7 (10.8) | 3 (14.3) | 4 (9.1) | 2 (8.0) | 0.838 |
